Cancer Drug Resistance
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig7

From:  Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance
Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance

Figure 7. (A) Design and features of 4T1 cytomembrane-camouflaged polydopamine nanoparticles for delivery of gambogic acid; (B) In vivo antitumor and antimetastatic efficacy. **P < 0.01 [reproduced with permission from Lan et al. (2024)[167]. Copyright 2024 John Wiley and Sons].

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties